The overall valuation of the market is expected to surpass USD 13,006.1 million by 2034, up from USD 6,489.3 million in 2024. A significant trend is the introduction of closed catheters for injecting tracers during computed tomography. The projected CAGR of 7.2% from 2024 to 2034 indicates high-pressure resistance.
| Attributes | Key Statistics |
|---|---|
| Expected Base Year Value (2024) | USD 6,489.3 million |
| Anticipated Forecast Value (2034) | USD 13,006.1 million |
| Estimated Growth (2024 to 2034) | 7.2% CAGR |
Explore FMI!
Book a free demo
Rise in the Number of Surgical Procedures Performed Worldwide
Surgical procedures often require the placement of an IV catheter to administer anesthesia, fluids, and medications during and after the surgery. With the increase in surgeries being conducted globally, the need for peripheral intravenous catheters has perceived an uptick.
Technological advancements in the design and materials used in peripheral intravenous catheters have significantly propelled the sector. The adoption of catheters that reduce the risk of infection, thrombosis, and phlebitis in healthcare facilities is on the rise. This progress in the healthcare sector is a testament to the industry's continuous evolution.
Plurality of Chronic Diseases
Cancer, diabetes, and cardiovascular disease cases have increased steadily, leading to a rise in the global peripheral intravenous catheter sector. Patients suffering from these conditions often require long-term hospitalization and frequent administration of medications or fluids through IV catheters. This has surged the peripheral intravenous catheter market expansion.
Among the restraining factors influencing the industry are
Ease of use, low cost, and high level of patient comfort make short PIVCs a prominent choice in the peripheral intravenous catheter market. These catheters are typically used for short-term intravenous therapy in hospitals and clinics. They are chosen over other types of catheters because they are smaller, making them less invasive and less painful for patients. The short peripheral IV catheter is backed up due to its many features, thus accounting for a flawless share of 35.10% in 2024.
| Attributes | Details |
|---|---|
| Product Type | Short Peripheral IV Catheter |
| Industry Share (2024) | 35.1% |
Demand for these catheters has surged due to the increasing prevalence of chronic diseases, coupled with the growing senior population. The rising need for efficient and effective medical devices in healthcare facilities is expected to surge the landscape for PIV catheters to continue to grow in the coming years.
Safety PIVC acquires the technological space of the peripheral intravenous catheter (PIVC) industry through its superior safety features and ease of use. Rising popularity of hospital-acquired infections (HAIs) and the need for safe and effective catheterization methods are increasing the adoption of this technology. With a share of 30.30% in 2024, safety PIVC technology tops the segment column in the peripheral intravenous catheter market.
| Attributes | Details |
|---|---|
| Technology | Safety PIVC |
| Industry Share (2024) | 30.3% |
Safety PIVCs prevent needlestick injuries to healthcare workers and reduce the risk of bloodstream infections in patients, thus making them picked choice among healthcare professionals. Its requirement is also attributed to the increasing use of PIVCs in various healthcare settings like hospitals, clinics, and home care.
Growing focus on patient safety and the need for cost-effective solutions in healthcare facilitates its success. The peripheral intravenous catheter market is catching the launch of innovative products with advanced safety features. Products like retractable needles, anti-reflux valves, and integrated needleless connectors are holding superior positions, making PIVCs a prominent player in the industry.
The peripheral intravenous catheter industry expansion has been observed in key Asian, European, and North American countries. With huge opportunities in Japan and Italy, setting a CAGR of 6.6% and 6.7%, respectively. The table shows the prominence of these countries in the industrial landscape, with India making its presence offering lucrative opportunities.
| Countries | CAGR from 2024 to 2034 |
|---|---|
| India | 7.5% |
| United States | 7.5% |
| China | 7% |
| Italy | 6.7% |
| Japan | 6.6% |
Increasing patient pool, expanding the healthcare industry, and favorable government support facilitate the development of healthcare sectors in India. Plus, rising prevalence of chronic diseases, increasing surgical procedures, and growing healthcare infrastructure also stand in a row for India’s industry expansion locally and internationally. This is accelerating the medical tourism sector. Indian landscape in this sector is estimated to surge a huge surplus, accounting for a CAGR of 7.5% through 2034, with an increase in local manufacturers selling goods at reduced prices.
Key players in the peripheral intravenous catheter market are Becton Dickinson and Company, B. Braun Melsungen AG, Teleflex Incorporated, and Smiths Medical. For instance, in a recent development, Becton Dickinson launched its Nexiva Closed IV Catheter System in India, offering advanced safety features and reducing the risk of needlestick injuries. Thus, companies are involved in addressing the growing need for safer and more efficient peripheral intravenous catheter solutions in India.
A sharp rise in the number of hospitalizations is playing a crucial role in pushing the demand for peripheral intravenous catheters in the United States. The trend is likely to continue during the forecast period. For instance, as per the 2020 AHA Annual Survey (FY 2020), total admissions in all USA hospitals reached 33,356,853. This pool of patients attracts the need for more medically equipped infrastructure. Thus, the peripheral intravenous catheter market increases.
Technological advancements like the development of advanced materials and improved catheter designs have enhanced the safety and efficacy of peripheral intravenous catheters. A CAGR of 7.5% through 2034 reflects the fast-paced development of the industry.
Ongoing mergers and acquisitions within the healthcare sector, coupled with an increasing number of surgeries and procedures, are spurring the peripheral intravenous catheter market in the United States. In addition, reimbursement practices for catheters, such as those offered by the Centers for Medicare and Medicaid in the USA, aid in sectoral expansion.
China is home to one of the largest populations in the world with more opportunities for healthcare professionals. Growing chronic diseases and the elderly population surge the demand for preventive measures against it.
Increasing healthcare spending, advancing medical technology, and accelerating growth of the medical tourism sector are subjects to the development of the Chinese peripheral intravenous catheter market. China is estimated to cover a CAGR of 7% from 2024 to 2034 with advanced technological development in the healthcare industry.
China also has one of the best laboratories and research centers, which fuels the healthcare sector's growth. The innovation and use of these PIVCs as a number of surgeries and trials are carried out on a daily basis, the scape is set to expand broadly in the foreseeable future.
Italy's strong healthcare infrastructure and government initiatives to improve healthcare services are soaring its growth. Italy’s influence on healthcare development globally is significant.
As it holds a strong position in advanced medical research and technology. Italy is also a big ground for the pharmaceutical industry. All these combine to advance and skyrocket the Italian lanscape expansion globally. Italy is seen to have a CAGR of 6.7% through 2034.
Major companies such as B. Braun Melsungen AG, Becton, Dickinson and Company, Smiths Medical, and others drove segment proliferation through product innovation and strategic collaborations.
Ascending preference among healthcare providers for peripheral intravenous catheters due to their ease of use and reduced risk of complications compared to traditional catheters fuels the industry.
Development of novel minimally invasive devices has improved patient comfort and safety, aiding in industrial success. The Japanese peripheral intravenous catheter market, with a CAGR of 6.6% from 2024 to 2034, widens its border in the healthcare sector.
Recent acquisitions by major players in the Japanese sector have spurred the sectorial arrow upside. For example, Terumo Corporation's acquisition of BD's soft tissue core needle biopsy product line has also contributed to market expansion, offering a wider range of high-quality products to healthcare facilities and providers.
Product launches, research, and mergers by major companies are guiding the competitiveness in the industry. Researchers are focused on more innovative and patient-centric developments and updating the peripheral intravenous catheter market.
With approval from the United States Food and Drug Administration (FDA) and the CE Mark in March 2022, Shockwave Medical, Inc. announced that the Shockwave M5+ peripheral IVL catheter is now commercially available throughout the world. The Shockwave M5+ catheter, whose launch has been restricted up to this point, is specially made to shorten IVL treatments, offer other access possibilities, and extend IVL therapy to patients with bigger vessel diameters
Recent Advancements
Industry is set to reach USD 6,489.3 million in 2024.
The sector is expected to reach USD 13,006.1 million by 2034.
The industry is set to report a CAGR of 7.2% from 2024 to 2034.
Safety PIVC is the top technology, with a share of 72.5% for 2024.
A CAGR of 7.5% is projected for the industry in the United States through 2034.
Based on product type, the industry is categorized into short peripheral IV catheter, ported PIVC, non-ported PIVC, integrated/closed PIVC, closed with extension sets, and closed PIVC.
When it comes to technology, the industry is classified into conventional PIVC, safety PIVC, closed with Extension Set, active PIVC with blood control, passive PIVC with blood control, active PIVC, passive PIVC
Key end users present in this industry are hospitals, ambulatory surgical centers (ASCs), clinics, home use, and others
The industry is scrutinized across key regions including North America, Latin America, Asia Pacific, Middle East and Africa (MEA), as well as Europe.
Peripheral Intravenous Catheter Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
